The legacy of Viagra and the pharmaceutical industry presents a challenging picture for careful investors. Initially, copyright's hugely successful drug transformed the treatment of erectile dysfunction, producing significant profits and defining the contemporary pharmaceutical landscape. However, patent expiration and the emergence of alternative